Previous Page  5 / 19 Next Page
Information
Show Menu
Previous Page 5 / 19 Next Page
Page Background

Gastro Education 2018

Journal of Clinical Gastroenterology and Hepatology

ISSN: 2575-7733

Page 19

September 06-07, 2018

London, UK

14

th

International Conference on

Gastro Education

Background:

Egypt has the highest prevalence of hepatitis

C virus in the world with infection rate up to 60%, for which

liver fibrosis or hepatic carcinoma is the final outcome.

Stem cell therapy provides a new hope for hepatic repair

instead of traditional treatment, liver transplantation, as it

is safer, gives long term engraftment and avoid expensive

immunosuppressive drugs and unexpected hazardous effects.

Aim:

This work aimed at determining the therapeutic potential

of mesenchymal stem cells (MSC) in hepatic repair as a new

line of therapy for liver fibrosis.

Methods:

Thirty three female albino rats were divided into three

groups: Group I: 10 rats injected subcutaneously with olive oil,

Group II: 13 rats injected with carbon tetrachloride (CCl4) and

Group III: 10 rats injected with CCl4 then bone marrow derived

MSC frommale rats. Blood and liver tissue samples were taken

from all rats for biochemical and histological study.

Results:

Liver functions for group II rats showed significant

deterioration in response to CCl4 in addition to significant

histological changes in liver lobules and portal areas. Those

parameters tend to be normal in MSC-treated group. Group III

rats revealed normalized liver function and histological picture.

Meanwhile, most of the pathological lesions were still detected

in rats of second group.

Conclusions:

Undifferentiated MSCs have the ability to

ameliorate CCl4 induced liver injury in albino rats in terms of

liver functions and histological features. So, stem cell therapy

can be considered clinically to offer a hope for patients

suffering from liver fibrosis.

Biography

Nermin Raafat pursued her MD-PhD from University of Basel, Switzerland.

She is currently an Assistant Professor of Medical Biochemistry and Mo-

lecular Biology at Zagazig University School of Medicine, Egypt. She is the

Director of Molecular Biology and Cell Culture Lab in the Department; Head

of Cell Culture Unit of Scientific and Medical Research Centre; Director of

Project Management Unit; Admin of Institutional Review Board and a Mem-

ber of Scientific Research Council at the same university. She has published

more than 30 papers in reputed journals and has participated in more than

30 international conferences.

nerminraafat@gmail.com

Mesenchymal stem cells:

in vivo

therapeutic application

ameliorates carbon tetrachloride induced liver fibrosis in rats

Nermin Raafat, Sara M Abdel Aal, Fadia K Abdo

and

Nabila M El Ghonaimy

Zagazig University, Egypt

Nermin Raafat et al., J Clin Gastroenterol Hepatol 2018, Volume 2

DOI: 10.21767/2575-7733-C2-005